Pharma & Biotech

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....

Precision Biosciences is solidifying its clinical development strategy, with a pivotal trial for a Duchenne muscular dystrophy (DMD) treatment taking...

Recent clinical trial data from Ocular Therapeutix has generated significant attention within ophthalmology investment circles. The company's key drug candidate,...

Iqvia Holdings Inc. is accelerating the digital transformation of the life sciences sector through a strategic technology alliance. The company...

In a volatile market for biotechnology stocks, Corvus Pharmaceuticals has achieved a significant milestone, granting the company a crucial period...

Grail finds itself at a pivotal juncture, marked by a significant change in executive leadership and a notable shift in...

To address overwhelming global demand for its blockbuster diabetes and weight-loss treatments, Eli Lilly and Company is embarking on another...

For emerging biotechnology firms such as InMed Pharmaceuticals, the current investment climate presents a dual challenge. Sustaining costly research operations...

The financial reporting crisis at packaging specialist Gerresheimer has entered a new phase, with legal action now a distinct possibility....

A significant strategic transition is underway at Mainz-based biotechnology firm BioNTech. While news of the impending departure of its two...